BeyondSpring Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BeyondSpring Inc. (BYSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 183.62 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- BeyondSpring Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 183.62K shares, a 18.30% decline year-over-year.
- BeyondSpring Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- BeyondSpring Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 224.75K shares.
- BeyondSpring Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was -187.61K shares.
- BeyondSpring Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 651.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 183.62K shares 10-Q · filed 2026-08-14 | 183.62K shares 10-Q · filed 2026-08-14 | ||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 224.75K shares derived: sum of 2 quarters · filed 2025-11-12 | 224.75K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 224.75K shares 10-Q · filed 2025-08-13 | 224.75K shares 10-Q · filed 2025-08-13 | ||
| 2024-12-31 | -187.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -187.61K shares derived: sum of 2 quarters · filed 2025-11-12 | 651.33K shares 10-K · filed 2025-03-27 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 838.94K shares 10-Q · filed 2025-11-12 | ||
| 2021-09-30 | 153.00K shares 6-K · filed 2021-12-30 | 954.29K shares derived: sum of 2 quarters · filed 2021-12-30 | 1.05M shares 6-K · filed 2021-12-30 | |
| 2021-06-30 | 801.29K shares 6-K · filed 2021-09-10 | 901.50K shares 6-K · filed 2021-09-10 | ||
| 2020-03-31 | 381.30K shares 6-K · filed 2020-06-11 | |||
| 2018-12-31 | 130.00K shares 20-F · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |